SNT Quarterly Shareholder Update - September 2019 31/10/19 PRICE SENSITIVE download Created with Sketch. 370.87KB Share SNT Pharmaxis Science Update - Anti-Fibrotic Pipeline 30/10/19 download Created with Sketch. 128.23KB Share SNT CEO Presentation to 2019 AusBiotech Conference 30/10/19 download Created with Sketch. 2.02MB Share SNT FDA Provides Guidance on Bronchitol Approval Steps 28/10/19 PRICE SENSITIVE download Created with Sketch. 103.32KB Share SNT Pharmaxis Cancer Drug Progressing in Clinic 24/10/19 download Created with Sketch. 155.87KB Share SNT Appendix 4G 18/10/19 download Created with Sketch. 91.67KB Share SNT Corporate Governance Statement 18/10/19 download Created with Sketch. 83.79KB Share SNT Notice of Annual General Meeting/Proxy Form 18/10/19 download Created with Sketch. 324.28KB Share SNT Annual Report to shareholders 18/10/19 download Created with Sketch. 781.33KB Share SNT Pharmaxis Receives $6.2m R&D Tax Incentive 17/10/19 PRICE SENSITIVE download Created with Sketch. 101.81KB Share SNT Appendix 3B - Exercise of Employee Options 12/09/19 download Created with Sketch. 127.92KB Share SNT Proposed Issue of Securities to CEO 15/08/19 download Created with Sketch. 110.85KB Share SNT Appendix 3B 2019 Grant of Performance Rights and Share Plan 15/08/19 download Created with Sketch. 130.57KB Share SNT Change of Director's Interest Notice-G Phillips Rights Lapse 15/08/19 download Created with Sketch. 70.43KB Share SNT Lapse of 2018 Performance Rights and Expiry of Options 15/08/19 download Created with Sketch. 107.35KB Share SNT Preliminary Final Report 15/08/19 PRICE SENSITIVE download Created with Sketch. 870.85KB Share SNT Investor Presentation 26/07/19 download Created with Sketch. 1.66MB Share SNT Quarterly Shareholder Update - June 2019 25/07/19 PRICE SENSITIVE download Created with Sketch. 395.58KB Share SNT Appendix 4C - quarterly 25/07/19 PRICE SENSITIVE download Created with Sketch. 120.79KB Share SNT Pathway to US Bronchitol Approval Clarified in FDA Response 20/06/19 PRICE SENSITIVE download Created with Sketch. 103.01KB Share SNT Change in substantial holding 30/05/19 download Created with Sketch. 372.92KB Share SNT US Advisory Committee Positive Recommendation on Bronchitol 09/05/19 PRICE SENSITIVE download Created with Sketch. 134.45KB Share SNT Quarterly Shareholder Update - March 2019 29/04/19 PRICE SENSITIVE download Created with Sketch. 390.02KB Share SNT Appendix 4C - quarterly 29/04/19 PRICE SENSITIVE download Created with Sketch. 123.23KB Share SNT Appendix 3B - Exercise of Employee Options 18/04/19 download Created with Sketch. 128.12KB Share SNT Investor Presentation 01/04/19 download Created with Sketch. 1.64MB Share SNT US FDA Convenes Advisory Committee for Bronchitol 26/03/19 download Created with Sketch. 100.72KB Share SNT Becoming a substantial holder 05/03/19 download Created with Sketch. 255.44KB Share SNT Ceasing to be a substantial holder 04/03/19 download Created with Sketch. 9.43KB Share SNT Boehringer Completes Enrollment of Phase 2A Trial in NASH 25/02/19 download Created with Sketch. 103.99KB Share SNT Pharmaxis Commences Phase 1 LOX Clinical Trial 22/02/19 PRICE SENSITIVE download Created with Sketch. 128.88KB Share SNT Half Yearly Report and Accounts 14/02/19 PRICE SENSITIVE download Created with Sketch. 553.93KB Share SNT Quarterly Shareholder Update - December 2018 30/01/19 PRICE SENSITIVE download Created with Sketch. 385.27KB Share SNT Appendix 4C - quarterly 30/01/19 PRICE SENSITIVE download Created with Sketch. 120.71KB Share SNT Pharmaxis Announces LOXL2 Program Phase 2 Ready 17/01/19 PRICE SENSITIVE download Created with Sketch. 116.23KB Share SNT PHARMAXIS ANNOUNCES RESUBMISSION OF BRONCHITOL NDA IN USA 20/12/18 PRICE SENSITIVE download Created with Sketch. 114.21KB Share SNT Pharmaxis Announces First Relaunch Sales of Aridol in USA 13/12/18 PRICE SENSITIVE download Created with Sketch. 116.72KB Share SNT Change in substantial holding 27/11/18 download Created with Sketch. 246.08KB Share SNT Appendix 3B - exercise of employee options 26/11/18 download Created with Sketch. 128.19KB Share SNT Final Director's Interest Notice 22/11/18 download Created with Sketch. 63.16KB Share SNT Change of Director's Interest Notice 22/11/18 download Created with Sketch. 70.48KB Share SNT Appendix 3B - Grant of options to CEO 22/11/18 download Created with Sketch. 130.2KB Share SNT Results of Meeting 22/11/18 download Created with Sketch. 83.09KB Share SNT Pharmaxis AGM - CEO Presentation 22/11/18 PRICE SENSITIVE download Created with Sketch. 1.17MB Share SNT Chairman's Address to Shareholders 22/11/18 PRICE SENSITIVE download Created with Sketch. 108.27KB Share SNT Pharmaxis AGM - Withdrawal of Resolution 22/11/18 download Created with Sketch. 75.95KB Share SNT Investor Research Briefing Presentations 20/11/18 download Created with Sketch. 3.31MB Share SNT LOX Inhibitor Program for Pancreatic Cancer Phase 1 Ready 20/11/18 PRICE SENSITIVE download Created with Sketch. 146.6KB Share SNT Pharmaxis Releases Positive Results of Phase 1 Clinical Tria 15/11/18 PRICE SENSITIVE download Created with Sketch. 117.37KB Share SNT Pharmaxis Investor Research Briefing 15/11/18 download Created with Sketch. 113.15KB Share SNT Quarterly Shareholder Update - September 2018 26/10/18 download Created with Sketch. 376.27KB Share SNT Appendix 4C - quarterly 26/10/18 PRICE SENSITIVE download Created with Sketch. 122.69KB Share SNT Copy of Corporate Governance Statement 19/10/18 download Created with Sketch. 61.78KB Share SNT Appendix 4G 19/10/18 download Created with Sketch. 120.63KB Share SNT Annual Report to shareholders 19/10/18 download Created with Sketch. 871.33KB Share SNT Notice of Annual General Meeting/Proxy Form 19/10/18 download Created with Sketch. 451.03KB Share SNT Updated Investor Presentation 11/10/18 download Created with Sketch. 1.21MB Share SNT Positive Phase 1 Results of Phase 1 Study - LOXL2 Inhibitor 11/10/18 PRICE SENSITIVE download Created with Sketch. 117.56KB Share SNT Director Retirement 04/10/18 download Created with Sketch. 113.05KB Share SNT Change in substantial holding 26/09/18 download Created with Sketch. 75.67KB Share SNT Appendix 3B - exercise of employee options 26/09/18 download Created with Sketch. 128.22KB Share SNT Change in substantial holding 25/09/18 download Created with Sketch. 218.37KB Share SNT Change in substantial holding from AEF 25/09/18 download Created with Sketch. 144.8KB Share SNT Appendix 3B - exercise of 25,000 employee options 21/09/18 download Created with Sketch. 128.22KB Share SNT Change of Director's Interest Notice - Metters 21/09/18 download Created with Sketch. 69.92KB Share SNT Change of Director's Interest Notice - W Delaat 21/09/18 download Created with Sketch. 70.36KB Share SNT Change of Director's Interest Notice - Phillips 21/09/18 download Created with Sketch. 71.89KB Share SNT Change of Director's Interest Notice - McComas 21/09/18 download Created with Sketch. 70.99KB Share SNT Change of Director's Interest Notice - S Buckingham 21/09/18 download Created with Sketch. 71.13KB Share SNT Section 708A Notice 21/09/18 download Created with Sketch. 52.63KB Share SNT Appendix 3B - Placement Tranche 2 21/09/18 download Created with Sketch. 129.12KB Share SNT Initial Director's Interest Notice - E Rayner 18/09/18 download Created with Sketch. 66.28KB Share SNT Director Appointment - Edward Rayner 18/09/18 download Created with Sketch. 114.57KB Share SNT Results of Meeting 17/09/18 download Created with Sketch. 230.81KB Share SNT Chairman's Introductory Comments to Shareholders 17/09/18 download Created with Sketch. 88.48KB Share SNT Investor Presentation 28/08/18 download Created with Sketch. 1.3MB Share SNT Notice of Extraordinary General Meeting/Proxy Form 20/08/18 download Created with Sketch. 614.56KB Share SNT Notice of initial substantial holder 17/08/18 download Created with Sketch. 296.1KB Share SNT Preliminary Final Report 17/08/18 PRICE SENSITIVE download Created with Sketch. 921.26KB Share SNT Change in substantial holding 16/08/18 download Created with Sketch. 63.62KB Share SNT FDA Factory Approval and Relaunch of Aridol in US Market 15/08/18 PRICE SENSITIVE download Created with Sketch. 124.73KB Share SNT Section 708A Notice 14/08/18 download Created with Sketch. 52.63KB Share SNT Appendix 3B - Placement Tranche 1 14/08/18 download Created with Sketch. 137.83KB Share SNT Capital Raising Presentation 06/08/18 PRICE SENSITIVE download Created with Sketch. 1.27MB Share SNT Pharmaxis Announces A$24m Placement 06/08/18 PRICE SENSITIVE download Created with Sketch. 127.66KB Share SNT Trading Halt Announcement - System Upgrade 06/08/18 PRICE SENSITIVE download Created with Sketch. 220.36KB Share SNT Trading Halt 03/08/18 PRICE SENSITIVE download Created with Sketch. 271.05KB Share SNT Quarterly Shareholder Update - June 2018 27/07/18 PRICE SENSITIVE download Created with Sketch. 441.24KB Share SNT Appendix 4C - quarterly 27/07/18 PRICE SENSITIVE download Created with Sketch. 122.6KB Share SNT Proposed Issue of Securities to Chief Executive Officer 25/07/18 download Created with Sketch. 111.76KB Share SNT Appendix 3B - Grant of Employee Options and Shares 25/07/18 download Created with Sketch. 130.93KB Share SNT Appendix 3B - Exercise of Employee Options 25/07/18 download Created with Sketch. 129.31KB Share SNT Appendix 3B - Exercise of Employee Options 17/07/18 download Created with Sketch. 129.32KB Share SNT Change of Director's Interest Notice - Expiring Options 02/07/18 download Created with Sketch. 71.02KB Share SNT LOXL2 Program Attracts Strong Partner Interest at BIO18 14/06/18 PRICE SENSITIVE download Created with Sketch. 120.63KB Share SNT Quarterly Shareholder Update - March 2018 30/04/18 PRICE SENSITIVE download Created with Sketch. 375.62KB Share SNT Appendix 4C - quarterly 30/04/18 PRICE SENSITIVE download Created with Sketch. 194.74KB Share SNT Change in substantial holding 05/04/18 download Created with Sketch. 215.26KB Share SNT Change in substantial holding from AEF 04/04/18 download Created with Sketch. 152.95KB Share SNT Appendix 3B - Exercise of Employee Options 08/03/18 download Created with Sketch. 130.63KB Share